Upload Avatar (500 x 500)
黄建英
Medical School
武汉大学
湖北省
Language: 中文, 英语
临床试验
药物评价
医疗器械
研究
转化
技术
医学科学
创新
监管合规
Gcp
Areas of Focus
- 药物与医疗器械临床评价研究
- 医学科技成果转化研究
Work Experience
- 武汉大学中南医院临床试验中心常务副主任、办公室主任
Academic Background & Achievements
- 从事新药临床评价工作30余年
- 现任武汉大学中南医院临床试验中心（国家药物临床试验机构）
Publications
- Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial, Shipo Wu, Jianying Huang, et al., 2021
- Multifunctional MOF-Based Microneedle Patch With Synergistic Chemo-Photodynamic Antibacterial Effect and Sustained Release of Growth Factor for Chronic Wound Healing, Zeng YN, Wang CY, Lei K, Xiao C, Jiang X, Zhang W, Wu LJ, Huang JY, Li W, 2023
- Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study, Feng Ying, Huang Jianying, Wu Jianyuan, Xu Yan, Chen Bo, Jiang Lijun, Xiang Hui, Peng Zhiyong, Wang Xinghuan, 2020
- Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects, Yixin Hu, Jianyuan Wu, Xin Jiang, Guiying Chen, Yang Zhang, Luqin Si, Hongliang Jiang, Jiangeng Huang, Jianying Huang, 2022
- Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial, Chen Chang, Zhang Yi, Huang Jianying, Yin Ping, Cheng Zhenshun, Wu Jianyuan, Chen Song, Zhang Yongxi, Chen Bo, Lu Mengxin, Ju Lingao, Zhang Jingyi, Wang Xinghuan, 2021
- Effect of SHR0302 on the Pharmacokinetics of CYP3A4, CYP2C8, CYP2C9, and CYP2C19 Probe Substrates in Healthy Volunteers: A Cocktail Analysis, Fu M, Luo L, Feng S, Lin H, Lu Z, Gu F, Fan Y, Wu B, Huang J, Shen K, 2023
Awards
- 全国巾帼建功标兵 (2021.03)
- 全省科协系统先进工作者 (2022.08)
- 湖北省百名优秀女性科技创新人才 (2020.09)
- 武汉市抗击新冠肺炎疫情先进个人 (2020)
- 湖北省科技进步奖二等奖，‘平战结合’临床研究平台建立及技术创新应用 (2022)
